Back to Search
BRIAN BLOUGH, PHARMD
PHARMD
Pharmacist
NPI: 1750024592Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PHA.0023871(CO)
Research & Publications (20)
Changes in feeding and locomotion induced by amphetamine analogs in rats.
PMID 19062203·Drug Alcohol Depend·2009
4-observational
Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine.
PMID 19151247·J Pharmacol Exp Ther·2009
7-preclinical
Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.
PMID 19086767·Exp Clin Psychopharmacol·2008
6-review
Dopamine/serotonin releasers as medications for stimulant addictions.
PMID 18772043·Prog Brain Res·2008
6-review
Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.
PMID 17408232·AAPS J·2007
6-review
Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.
PMID 17602602·J Med Chem·2007
7-preclinical
Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.
PMID 17071819·J Pharmacol Exp Ther·2007
7-preclinical
Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.
PMID 17056126·Trends Pharmacol Sci·2006
7-preclinical
Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.
PMID 16854064·J Med Chem·2006
7-preclinical
Interaction of amphetamines and related compounds at the vesicular monoamine transporter.
PMID 16835371·J Pharmacol Exp Ther·2006
7-preclinical
Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
PMID 15761112·J Pharmacol Exp Ther·2005
7-preclinical
Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compounds.
PMID 15916437·J Med Chem·2005
7-preclinical
Synthesis and monoamine transporter binding properties of 3beta-(3',4'-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters.
PMID 15828814·J Med Chem·2005
8-other
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs.
PMID 15677348·J Pharmacol Exp Ther·2005
4-observational
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
PMID 15496938·Neuropsychopharmacology·2005
7-preclinical
Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
PMID 15542717·Ann N Y Acad Sci·2004
4-observational
Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
PMID 15322260·Mol Pharmacol·2004
7-preclinical
3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
PMID 12761331·Mol Pharmacol·2003
7-preclinical
Appetite suppressants as agonist substitution therapies for stimulant dependence.
PMID 12105089·Ann N Y Acad Sci·2002
7-preclinical
Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.
PMID 12106802·Eur J Pharmacol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 40 COUNTY ROAD 804
FRASER, CO 80442 - Phone
- (970) 726-6920
Quick Facts
- NPI
- 1750024592
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile